204 related articles for article (PubMed ID: 22608541)
1. Health-related quality of life for men with prostate cancer--an evaluation of outcomes 12-24 months after treatment.
Brassell SA; Elsamanoudi SI; Cullen J; Williams ME; McLeod DG
Urol Oncol; 2013 Nov; 31(8):1504-10. PubMed ID: 22608541
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive quality-of-life outcomes in the setting of a multidisciplinary, equal access prostate cancer clinic.
Rice K; Hudak J; Peay K; Elsamanoudi S; Travis J; Lockhart R; Cullen J; Black L; Houge S; Brassell S
Urology; 2010 Nov; 76(5):1231-8. PubMed ID: 20579698
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.
Banerji JS; Hurwitz LM; Cullen J; Wolff EM; Levie KE; Rosner IL; Brand TC; LʼEsperance JO; Sterbis JR; Porter CR
Urol Oncol; 2017 May; 35(5):234-242. PubMed ID: 28110975
[TBL] [Abstract][Full Text] [Related]
4. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.
Tyson MD; Alvarez J; Koyama T; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen VW; Penson DF; Barocas DA
Eur Urol; 2017 Aug; 72(2):307-314. PubMed ID: 27816300
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of health-related quality of life outcomes among men treated for intermediate- and high-risk prostate cancer: the impact of primary and secondary therapies.
Alsinnawi M; Cullen J; Hurwitz LM; Levie KE; Burns JF; Rosner IL; Brand TC; Stroup S; Sterbis JR; Rice K; Conti G; Porter CR
Can J Urol; 2019 Aug; 26(4):9809-9820. PubMed ID: 31469635
[TBL] [Abstract][Full Text] [Related]
6. Prospective Long-term Health-related Quality of Life Outcomes After Surgery, Radiotherapy, or Active Surveillance for Localized Prostate Cancer.
Kord E; Jung N; Posielski N; Jiang J; Elsamanoudi S; Chesnut GT; Speir R; Stroup S; Musser J; Ernest A; Tausch T; Flores JP; Porter C
Eur Urol Open Sci; 2023 Feb; 48():60-69. PubMed ID: 36743401
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
Jayadevappa R; Chhatre S; Whittington R; Bloom BS; Wein AJ; Malkowicz SB
BJU Int; 2006 May; 97(5):955-62. PubMed ID: 16643477
[TBL] [Abstract][Full Text] [Related]
8. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.
Lee WR; Hall MC; McQuellon RP; Case LD; McCullough DL
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):614-23. PubMed ID: 11597800
[TBL] [Abstract][Full Text] [Related]
9. Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients.
Jayadevappa R; Johnson JC; Chhatre S; Wein AJ; Malkowicz SB
Cancer; 2007 Jun; 109(11):2229-38. PubMed ID: 17443664
[TBL] [Abstract][Full Text] [Related]
10. Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification.
Takizawa I; Hara N; Nishiyama T; Kaneko M; Hoshii T; Tsuchida E; Takahashi K
Asian J Androl; 2009 May; 11(3):283-90. PubMed ID: 19349948
[TBL] [Abstract][Full Text] [Related]
11. Quality of life among elderly men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
Namiki S; Ishidoya S; Kawamura S; Tochigi T; Arai Y
J Cancer Res Clin Oncol; 2010 Mar; 136(3):379-86. PubMed ID: 19727818
[TBL] [Abstract][Full Text] [Related]
12. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported functional outcome measures and treatment choice for prostate cancer.
Tiruye T; O'Callaghan M; Moretti K; Jay A; Higgs B; Santoro K; Boyle T; Ettridge K; Beckmann K
BMC Urol; 2022 Nov; 22(1):169. PubMed ID: 36335325
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal regret after treatment for low- and intermediate-risk prostate cancer.
Hurwitz LM; Cullen J; Kim DJ; Elsamanoudi S; Hudak J; Colston M; Travis J; Kuo HC; Rice KR; Porter CR; Rosner IL
Cancer; 2017 Nov; 123(21):4252-4258. PubMed ID: 28678408
[TBL] [Abstract][Full Text] [Related]
15. Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results.
Tyson MD; Koyama T; Lee D; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen V; Conwill R; McCollum D; Penson DF; Barocas DA
Eur Urol; 2018 Jul; 74(1):26-33. PubMed ID: 29501451
[TBL] [Abstract][Full Text] [Related]
16. Association between utility and treatment among patients with prostate cancer.
Jayadevappa R; Schwartz JS; Chhatre S; Wein AJ; Malkowicz SB
Qual Life Res; 2010 Jun; 19(5):711-20. PubMed ID: 20204704
[TBL] [Abstract][Full Text] [Related]
17. The effect of race on treatment patterns and subsequent health-related quality of life outcomes in men undergoing treatment for localized prostate cancer.
Posielski NM; Shanmuga S; Ho O; Jiang J; Elsamanoudi S; Speir R; Stroup S; Musser J; Ernest A; Chesnut GT; Tausch T; Flores JP; Porter C
Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):415-420. PubMed ID: 36357592
[TBL] [Abstract][Full Text] [Related]
18. Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.
Guedea F; Ferrer M; Pera J; Aguiló F; Boladeras A; Suárez JF; Cunillera O; Ferrer F; Pardo Y; Martínez E; Ventura M
Clin Transl Oncol; 2009 Jul; 11(7):470-8. PubMed ID: 19574206
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.
Wei JT; Dunn RL; Litwin MS; Sandler HM; Sanda MG
Urology; 2000 Dec; 56(6):899-905. PubMed ID: 11113727
[TBL] [Abstract][Full Text] [Related]
20. Long-term quality of life following primary treatment in men with clinical stage T3 prostate cancer.
Namiki S; Tochigi T; Ishidoya S; Ito A; Numata I; Arai Y
Qual Life Res; 2011 Feb; 20(1):111-8. PubMed ID: 20680687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
